IRVING, Texas, April 03, 2017 (GLOBE NEWSWIRE) — Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata” or “the Company”), a clinical-stage biopharmaceutical company, today announced that it entered into a $35 million loan and security agreement with Oxford Finance LLC and Silicon Valley Bank. Proceeds from the loan will be utilized primarily to support Reata’s multiple Phase 2 ...
The post Reata Pharmaceuticals, Inc. Secures $35 Million Term Loan Facility appeared first on ForexTV.
April 03, 2017 at 04:09PM
http://ift.tt/2oPWnxk
from Nasdaq NewsFeed
http://ift.tt/2oPWnxk
No comments:
Post a Comment